Last updated: 7 May 2024 at 9:03pm EST

Bruce Perkins Net Worth




The estimated Net Worth of Bruce D Perkins is at least $4.95 Milion dollars as of 1 September 2021. Mr. Perkins owns over 11,511 units of Amedisys stock worth over $1,728,290 and over the last 12 years he sold AMED stock worth over $2,947,743. In addition, he makes $271,089 as Independent Director at Amedisys.

Mr. Perkins AMED stock SEC Form 4 insiders trading

Bruce has made over 13 trades of the Amedisys stock since 2013, according to the Form 4 filled with the SEC. Most recently he sold 11,511 units of AMED stock worth $2,106,513 on 1 September 2021.

The largest trade he's ever made was selling 11,511 units of Amedisys stock on 1 September 2021 worth over $2,106,513. On average, Bruce trades about 1,394 units every 89 days since 2012. As of 1 September 2021 he still owns at least 17,869 units of Amedisys stock.

You can see the complete history of Mr. Perkins stock trades at the bottom of the page.





Bruce Perkins biography

Bruce D. Perkins serves as Independent Director of the Company. He is currently the managing member for Perkins, Smith & Associates, L.L.C. (“PSA”), a healthcare consulting firm based in Louisville, Kentucky. He also serves on the boards of three private companies: Advanced Dermatology and Cosmetic Surgery; Physician’s Endoscopy; and Remedi SeniorCare. Additionally, Mr. Perkins serves as a strategic executive for myNEXUS; a strategic advisor and executive coach for ChenMed; a senior advisor for the Marwood Group; a senior advisor for US Imaging; a consultant for Devoted Health and a consultant for Magellan Health, Inc. Previously, Mr. Perkins served as a board member of Athletico, LHP Hospital Group, Humana Health Plan of Puerto Rico, and was chairman of the board of MCCI Group Holdings. From 2015 to 2019, Mr. Perkins held the role of Strategic Executive and Advisor to the Chairman and CEO of MCCI Group Holdings and its successor, Conviva Health Solutions. Mr. Perkins retired from Humana Inc. in 2014 after a thirty-eight-year career. Prior to retirement, he was the President of Healthcare Services, a $21 billion business segment which included pharmacy, home care, behavioral health, physician services, provider networks, provider administration, and clinical platforms. Before Mr. Perkins became President of Healthcare Services, he served as Regional Vice President and Divisional President for Humana health plans. Prior to Humana’s spin-off of its hospital business, Mr. Perkins held multiple hospital leadership positions including Divisional Vice President and Hospital CEO, COO, and CFO. Director Qualifications: Extensive Knowledge of the Healthcare Industry—Mr. Perkins has over 43 years of experience in the healthcare industry. Relevant Executive/Leadership Experience—Mr. Perkins is the managing member for Perkins, Smith, & Associates, L.L.C., a private healthcare consulting company, and previously served as the President of Humana’s Healthcare Services Segment, which had annual revenue of $21 billion.

What is the salary of Bruce Perkins?

As the Independent Director of Amedisys, the total compensation of Bruce Perkins at Amedisys is $271,089. There are 13 executives at Amedisys getting paid more, with Paul Kusserow having the highest compensation of $12,835,500.



How old is Bruce Perkins?

Bruce Perkins is 66, he's been the Independent Director of Amedisys since 2015. There are 1 older and 19 younger executives at Amedisys. The oldest executive at Amedisys Inc. is Molly Coye, 72, who is the Independent Director.

What's Bruce Perkins's mailing address?

Bruce's mailing address filed with the SEC is 3854 AMERICAN WAY, SUITE A, , BATON ROUGE, LA, 70816.

Insiders trading at Amedisys

Over the last 27 years, insiders at Amedisys have traded over $269,564,877 worth of Amedisys stock and bought 2,690,968 units worth $38,198,016 . The most active insiders traders include Asset Management Llc Kohlbe..., Tide Capital, Llc North Tid... a David Nierenberg. On average, Amedisys executives and independent directors trade stock every 29 days with the average trade being worth of $2,494,602. The most recent stock trade was executed by Richard M Ashworth on 26 December 2023, trading 11,237 units of AMED stock currently worth $896,937.



What does Amedisys do?

amedisys is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients across the country to age in place. from home health to hospice to personal care, amedisys team members provide quality, clinically-distinctive care to more than 376,000 patients every year. every life is precious and tells an incredible story, and we celebrate that each day by honoring our patients with genuine, personal attention. everything we do, from the boardroom to our nationwide network of care centers, is centered on the best care possible for those who have entrusted us with their well-being and comfort. we work closely with doctors and other healthcare providers to coordinate services, and every patient has an individual plan of care that meets their specific needs. amedisys recognizes that nothing we do is possible without our incredible team. for all employees, whether they’re on the front lines delivering direct care or supporting our clinical team, this i



Complete history of Mr. Perkins stock trades at Amedisys a Humana

Osoba
Trans.
Transakce
Celková cena
Bruce D Perkins
Ředitel
Prodej $2,106,513
1 Sep 2021
Bruce D Perkins
Ředitel
Koupě $259,380
1 Mar 2021
Bruce D Perkins
Ředitel
Koupě $334,960
12 Jun 2020
Bruce D Perkins
Ředitel
Koupě $306,320
12 Mar 2020
Bruce D Perkins
Ředitel
Koupě $279,600
15 May 2019
Bruce D Perkins
Ředitel
Koupě $93,200
2 Aug 2017
Bruce D Perkins
Ředitel
Koupě $29,845
25 May 2017
Bruce D Perkins
Ředitel
Koupě $50,210
13 May 2016
Bruce D Perkins
Ředitel
Koupě $50,210
13 May 2016
Bruce D Perkins
Ředitel
Koupě $129,210
31 Jul 2015
Bruce D Perkins
Sgmnt Pres, Health a Well-Being
Využití opce $1,250
17 Feb 2014
Bruce D Perkins
Sgmnt Pres, Health a Well-Being
Prodej $841,230
13 Aug 2013
Bruce D Perkins
Sgmnt Pres, Health a Well-Being
Využití opce $1,008
18 Feb 2013


Amedisys executives and stock owners

Amedisys executives and other stock owners filed with the SEC include: